Welcome to our dedicated page for Blum Holdings SEC filings (Ticker: BLMH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cannabis disclosures can be a maze—especially when one company operates cultivation sites, retail dispensaries and multiple licensed subsidiaries. Blum Holdings (BLMH) packs all of that detail, plus tax code 280E nuances, into hundreds of SEC pages. If finding cash flow from flower sales or updates on state licenses feels overwhelming, you are not alone.
Stock Titan’s AI reads every line so you do not have to. Need Blum Holdings insider trading Form 4 transactions or alerts on Blum Holdings Form 4 insider transactions real-time? They land instantly in your dashboard. Wonder what changed in the latest Blum Holdings quarterly earnings report 10-Q filing or want a Blum Holdings annual report 10-K simplified? Our AI summary highlights segment revenue, cultivation yield data and risk-factor shifts. It also ties each Blum Holdings 8-K material events explained to potential market impact, from new dispensary openings to legal settlements.
Use the platform to:
- Compare retail vs. wholesale margins with one-click Blum Holdings earnings report filing analysis
- Track executive incentives through the Blum Holdings proxy statement executive compensation section
- Spot patterns in Blum Holdings executive stock transactions Form 4 before they hit headlines
Blum Holdings, Inc. insider Douglas Rosenberg reported his beneficial ownership of derivative securities as of 12/05/2025. Rosenberg, identified as a director of BLUM HOLDINGS, INC. (BLMH), holds multiple warrants to purchase the company’s common stock with different exercise and expiration dates.
The reported positions include warrants to purchase common stock at exercise prices of $0.17, $0.35, and $0.53 per share, each with specific expiration dates ranging from 12/30/2027 to 12/05/2028. The filing explains that the warrants are exercisable at any time for the underlying registered common stock and, if the underlying shares are unregistered, they may be exercised on a cashless basis at the holder’s election until they are automatically exercised on a cashless basis at expiration.
Blum Holdings, Inc. disclosed that it has closed the acquisition of all outstanding equity of a cannabis retail dispensary located in the Bay Area. This means the company now fully owns that dispensary business. The update was shared through a press release dated December 18, 2025, which is included as an exhibit to the report and incorporated by reference for more detail.
The information is furnished under a Regulation FD disclosure item, so it is intended to provide equal access to this operational update without being treated as filed financial information under securities laws.
Blum Holdings, Inc. entered into a series of unsecured promissory notes with a related accredited investor between December 1 and December 5, 2025, for principal amounts of $200,000, $200,000, $500,000, $100,000, and $500,000. The notes mature between late 2027 dates, bear 8.0% annual interest payable monthly starting March 31, 2026, and may be prepaid at any time without penalty.
Each note is convertible at the lender’s election into a convertible promissory note that provides for automatic conversion into Blüm capital stock at a price equal to 85% of a $20,900,000 pre-money valuation, or $0.98 per share on a fully diluted basis. In connection with these financings, the company issued common stock purchase warrants with an exercise price of $0.35 per share for up to 228,571, 228,571, 571,429, 114,286, and 571,429 shares, respectively, generally exercisable until various dates in December 2028 and automatically exercised on a cashless basis at expiration if the underlying shares remain unregistered.
Blum Holdings, Inc. (BLMH) reported that effective November 17, 2025, director Matthew Barron resigned from its Board of Directors. He also stepped down from his role on the Company’s Audit Committee.
The Company stated that Mr. Barron’s resignation was not due to any disagreement with Blum Holdings regarding its operations, policies, or practices. No other leadership or financial changes were disclosed in this report.
BLUM Holdings, Inc. reported an insider debt-for-equity conversion and share issuance involving its CEO. On 11/13/2025, accounts payable of
Blum Holdings, Inc. furnished a press release with fiscal third-quarter results and disclosed multiple equity issuances on
The Company issued 1,530,612 shares to Adnant, LLC, a related party, as repayment of accounts payable totaling
For transaction-related matters, the Company issued 1,809,270 shares to former stockholders of Safe Accessible Solutions, Inc. and 1,702,352 shares to shareholders of Coastal Pine Holdings, Inc. as amendment fees tied to agreements executed
Blum Holdings, Inc. reported Q3 2025 results. Revenue was $4.847 million (up from $4.364 million), gross profit was $2.322 million, and the company posted a net loss of $2.559 million. For the nine months, revenue reached $10.565 million with a net loss of $5.010 million.
The balance sheet shows total assets of $45.081 million and total liabilities of $52.349 million, resulting in a stockholders’ deficit of $11.879 million. Current income taxes payable were $10.904 million, with additional accrued income taxes of $13.500 million. Cash and cash equivalents were $0.388 million, and management disclosed substantial doubt about the company’s ability to continue as a going concern.
Blum expanded its retail footprint via management agreements tied to acquisitions of EWCR (Santa Clara County) and GDR (Redding), operating five California retail locations as of September 30, 2025. Shares outstanding were 13,553,473 as of September 30, 2025. As of November 13, 2025, common shares outstanding were 25,230,686.
Blüm Holdings, Inc. executed two unsecured promissory notes on September 16 and 17, 2025 for $500,000 and $250,000 respectively, creating $750,000 of principal indebtedness due in 2027. Each note bears an 8.0% annual interest rate payable monthly in arrears beginning January 15, 2026, and may be prepaid without penalty. At the lender's election each note is convertible into a convertible promissory note that will automatically convert into Blüm common stock at a conversion price equal to 85% of a $20,900,000 pre-money valuation (implying $0.98 per share on a fully diluted basis). The company also issued warrants: up to 571,429 shares exercisable at $0.35 per share for the $500,000 note and up to 285,714 shares at $0.35 per share for the $250,000 note. The $500,000 note formalizes funds advanced on August 11, 2025. Full terms are filed as Exhibits 10.1 and 10.2.
Blüm Holdings filed Amendment No. 1 to its Form 8-K to correct its prior disclosure about a previously announced management services transaction with a licensed Northern California cannabis retail operator. The amendment states that Blüm originally reported it would file financial statements and pro forma financial information for the target within 71 days, but after further analysis concluded those filings are not required because the Transaction is not "significant" under Regulation S-X. The amendment therefore removes references to any subsequent filing of financial statements or pro forma information; no financial statements or pro forma information are provided.